Iron Metabolism Parameters At First Trimester and preGnancy outcomE
IMAGE
Clinical and Biological Predictive Factors of Iron Deficiency Anemia in the Third Trimester of Pregnancy
2 other identifiers
observational
865
1 country
1
Brief Summary
Iron deficiency anemia is the leading cause of anemia during pregnancy, which can still reach 10 to 20% of pregnant women in developed countries, with potentially serious consequences for the child. Systematic iron supplementation remains controversial. This study aims to identify in the first trimester of pregnancy clinical and biological predictive factors for the occurrence of iron deficiency anemia in the third trimester of pregnancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2015
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 12, 2015
CompletedFirst Submitted
Initial submission to the registry
May 30, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2017
CompletedFirst Posted
Study publicly available on registry
June 5, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2018
CompletedJune 5, 2017
May 1, 2017
1.6 years
May 30, 2017
June 1, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hemoglobin value
in the third trimestry of pregnancy
Secondary Outcomes (3)
Rate of clinical and biological factors per patient
at the first trimestry of pregnancy
Rate of demographics and clinical factors per patient
at the first trimestry of pregnancy
Rate of biological factors per patient
at the first trimestry of pregnancy
Study Arms (1)
Pregnant women
Pregnant women are included during the ultrasound of T1. Written consent will be sought after delivery of the information notice.
Interventions
The prevalence of iron deficiency anemia is determined at T3 (after 34 SA). The predictive factors for this anemia will be sought according to the data collected in T1.
Eligibility Criteria
The women were screened at the maternity clinic of the gynecology-obstetrics department of CHU Estaing in Clermont-Ferrand, France.
You may qualify if:
- Pregnant women in the first trimester between 11SA and 13 SA + 6 days
- A written agreement is needed
You may not qualify if:
- Women who do not know enough about reading and writing French to answer questionnaires
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Clermont-Ferrand
Clermont-Ferrand, Auvergne, 63003, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marc RUIVARD, MD, PhD
CHU de Clermont-Ferrand
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 30, 2017
First Posted
June 5, 2017
Study Start
November 12, 2015
Primary Completion
June 1, 2017
Study Completion
January 1, 2018
Last Updated
June 5, 2017
Record last verified: 2017-05